Claire Leurent
InvestorManaging Director at AbbVie
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Claire
959 people in our graph can introduce you to Claire.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Kobe to introduce you to Claire
You →Kobe · together at Johnson & Johnson (2019–2020) →Claire
Ask Jamie Chen to introduce you to Claire
You →Jamie · 10 people · together at Johnson & Johnson →Claire
Ask Sam Okafor to introduce you to Claire
You →Sam · together at Vor Biopharma →Claire
Sign up to find every way you can get introduced to Claire
- Your email: the people you already email who know Claire
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Claire
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Claire Leurent pairs drug-development experience at Pfizer and Wyeth with cross-institutional venture investing at Samsung, J&J and the NIH, and—while teaching strategy at Northeastern—creates custom deal structures across stages.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtech
Experience
- AbbVie VenturesManaging Directorcurrent2024 — present
- The National Institutes of HealthEntrepreneur in Residence2023 — 2024Bethesda, Maryland, United States
- Johnson & JohnsonPrincipal, Venture Investments @ JJDC2019 — 2023
- Locus Biosciences, Inc.Board Observer2022
- POINT BiopharmaInvestor2021 — 2022
- PaigeInvestor2021 — 2022New York City Metropolitan Area
- CuraSen Therapeutics, Inc.Board Observer2020 — 2022
- X-Vax Technology, Inc.Board Observer2020 — 2022
- Vor BiopharmaBoard Observer2019 — 2020
- Samsung Venture InvestmentManaging Director2018 — 2019Greater Boston Area
- Samsung Venture InvestmentBio Sector Investment Director - Samsung Ventures America2017 — 2019
- Digital AssetInvestor2019
- Adicet Bio, IncInvestor2019
- WelldocBoard Observer2019
- Pillo HealthBoard Observer2019Boston, Massachusetts
- PfizerDirector - Neuroscience Clinical Research2010 — 2017Cambridge, Massachusetts
- PfizerSenior Clinical Scientist2004 — 2010
- Forenap PharmaProject Manager2003 — 2004
- IGBMC - Institut de Génétique et de Biologie Moléculaire - Strasbourg-Illkirch/FrancePhD1999 — 2003
Skills & more
+12 more
GCPOncologyRegulatory AffairsBusiness DevelopmentRegulatory SubmissionsTherapeutic AreasImmunologyFDANeurologyMentoringINDVaccinesFrom Claire's professional profile.
Colleagues at AbbVie
Frequently asked questions
- Who is Claire Leurent?
- Claire Leurent pairs drug-development experience at Pfizer and Wyeth with cross-institutional venture investing at Samsung, J&J and the NIH, and—while teaching strategy at Northeastern—creates custom deal structures across stages.
- Where does Claire Leurent work?
- Claire Leurent is Managing Director at AbbVie.
- What does Claire Leurent invest in?
- Claire Leurent invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
- What check size does Claire Leurent write?
- Claire Leurent typically writes checks of $100K – $5M.
- Where did Claire Leurent go to school?
- Claire Leurent studied at MIT Sloan School of Management (Master of Business Administration (MBA), Business Administration and Management); Pierre and Marie Curie University (Certification in CNS Pharmacology); Université Louis Pasteur (Strasbourg I) (PhD, Molecular and Cellular Biology).
Same school
Also attended MIT Sloan School of Management1,039
+ 1,033 more
Also attended Pierre and Marie Curie University100
+ 94 more
Also attended Université Louis Pasteur (Strasbourg I)8
+ 2 more
Also attended University of Strasbourg31
+ 25 more
Shared employers
Also worked at Locus Biosciences, Inc.9
+ 3 more
Also worked at Paige5
Also worked at CuraSen Therapeutics, Inc.3
Also worked at Samsung Venture Investment8
+ 2 more



























































